https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38201 Wed 11 Aug 2021 10:05:47 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15585 Wed 11 Apr 2018 13:13:24 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43929 Wed 05 Oct 2022 12:37:26 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38594 Trichomonas vaginalis, bacterial vaginosis and possibly genital ulcer disease. For herpes simplex virus type 2, Chlamydia trachomatis, Treponema pallidum, human immunodeficiency virus and candidiasis, the evidence is mixed. Male partner MC did not reduce risk of gonorrhea, Mycoplasma genitalium, dysuria or vaginal discharge in women. Conclusion: MC reduces risk of oncogenic HPV genotypes, cervical cancer, T. vaginalis, bacterial vaginosis and possibly genital ulcer disease in women. The reduction in risk of these STIs and cervical cancer adds to the data supporting global efforts to deploy MC as a health-promoting and life-saving public health measure and supplements other STI prevention strategies.]]> Tue 16 Nov 2021 15:04:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36014 Thu 14 Apr 2022 11:04:49 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32911 Thu 14 Apr 2022 11:01:47 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9060 Sat 24 Mar 2018 08:41:04 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8065 Sat 24 Mar 2018 08:34:28 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8066 Sat 24 Mar 2018 08:34:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12555 Sat 24 Mar 2018 08:17:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:11023 Sat 24 Mar 2018 08:11:49 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16927 Sat 24 Mar 2018 08:00:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45410 Fri 28 Oct 2022 11:52:48 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29205 p < 0.005). Women were also more likely to be tested for STIs than men when visiting the clinic (49.7 versus 40.3%, p = 0.015). Major barriers to men's seeking STI testing included a sense of shame from being seen visiting the clinic by women, men's lack of understanding of STIs and the need for testing, and inadequate access to male clinicians. Increasing men's access to healthcare and STI testing requires offering testing at a gender-sensitive and separate locations, and community-based sexual health promotion to increase knowledge of STIs.]]> Fri 22 Apr 2022 10:26:28 AEST ]]>